Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer science

Showing results (281-290 of 7,107) with videos related to

Pageof 711
Sort By:
Cancer Science|May 25, 2021
VLX1570 induces apoptosis through the generation of ROS and induction of ER stress on leukemia cell linesNami Kurozumi, Takayuki Tsujioka, Mamoru Ouchida, et al.
Cancer Science|August 6, 2021
Epidemiology of adult T-cell leukemia-lymphoma in Japan: An updated analysis, 2012-2013Shigeki Ito, Masako Iwanaga, Kisato Nosaka, et al.
Cancer Science|August 12, 2021
WEE1 inhibitor and ataxia telangiectasia and RAD3-related inhibitor trigger stimulator of interferon gene-dependent immune response and enhance tumor treatment efficacy through programmed death-ligand 1 blockadeXue Wu, Xiaoyan Kang, Xiaoxiao Zhang, et al.
Cancer Science|August 12, 2021
Tissue factor and its procoagulant activity on cancer-associated thromboembolism in pancreatic cancerSatoshi Kobayashi, Shiro Koizume, Tomoko Takahashi, et al.
Cancer Science|August 12, 2021
miR-221 confers lapatinib resistance by negatively regulating p27<sup>kip1</sup> in HER2-positive breast cancerThanh Kieu Huynh, Chih-Hao Huang, Jhen-Yu Chen, et al.
Cancer Science|August 25, 2021
Real-world safety of nivolumab in patients with non-small-cell lung cancer in Japan: Postmarketing surveillanceNobuyuki Yamamoto, Yoichi Nakanishi, Akihiko Gemma, et al.
Cancer Science|May 25, 2021
An AKT/PRMT5/SREBP1 axis in lung adenocarcinoma regulates de novo lipogenesis and tumor growthLiu Liu, Hui Yan, Maomei Ruan, et al.
Cancer Science|June 20, 2020
HTLV-1 seropositive patients with lung cancer treated with PD-1 inhibitorsYasuto Yoneshima, Koji Kato, Haruna Minami, et al.
Cancer Science|August 24, 2022
Induction of potent antitumor immunity by intradermal DNA injection using a novel needle-free pyro-drive jet injectorShinya Inoue, Izuru Mizoguchi, Jukito Sonoda, et al.
Cancer Science|December 15, 2004
Perspectives on cancer immuno-epidemiologyKei Nakachi, Tomonori Hayashi, Kazue Imai, et al.
Pageof 711

Showing results (281-290 of 7,107) with videos related to

Sort By:
Pageof 711
Cancer Science|May 25, 2021
VLX1570 induces apoptosis through the generation of ROS and induction of ER stress on leukemia cell linesNami Kurozumi, Takayuki Tsujioka, Mamoru Ouchida, et al.
Cancer Science|August 6, 2021
Epidemiology of adult T-cell leukemia-lymphoma in Japan: An updated analysis, 2012-2013Shigeki Ito, Masako Iwanaga, Kisato Nosaka, et al.
Cancer Science|August 12, 2021
WEE1 inhibitor and ataxia telangiectasia and RAD3-related inhibitor trigger stimulator of interferon gene-dependent immune response and enhance tumor treatment efficacy through programmed death-ligand 1 blockadeXue Wu, Xiaoyan Kang, Xiaoxiao Zhang, et al.
Cancer Science|August 12, 2021
Tissue factor and its procoagulant activity on cancer-associated thromboembolism in pancreatic cancerSatoshi Kobayashi, Shiro Koizume, Tomoko Takahashi, et al.
Cancer Science|August 12, 2021
miR-221 confers lapatinib resistance by negatively regulating p27<sup>kip1</sup> in HER2-positive breast cancerThanh Kieu Huynh, Chih-Hao Huang, Jhen-Yu Chen, et al.
Cancer Science|August 25, 2021
Real-world safety of nivolumab in patients with non-small-cell lung cancer in Japan: Postmarketing surveillanceNobuyuki Yamamoto, Yoichi Nakanishi, Akihiko Gemma, et al.
Cancer Science|May 25, 2021
An AKT/PRMT5/SREBP1 axis in lung adenocarcinoma regulates de novo lipogenesis and tumor growthLiu Liu, Hui Yan, Maomei Ruan, et al.
Cancer Science|June 20, 2020
HTLV-1 seropositive patients with lung cancer treated with PD-1 inhibitorsYasuto Yoneshima, Koji Kato, Haruna Minami, et al.
Cancer Science|August 24, 2022
Induction of potent antitumor immunity by intradermal DNA injection using a novel needle-free pyro-drive jet injectorShinya Inoue, Izuru Mizoguchi, Jukito Sonoda, et al.
Cancer Science|December 15, 2004
Perspectives on cancer immuno-epidemiologyKei Nakachi, Tomonori Hayashi, Kazue Imai, et al.
Pageof 711